In an unprecedented move within the biotech sector, Dewpoint Therapeutics and Mitsubishi have announced a potent alliance, pooling resources in a bold $480 million research collaboration. Their shared goal? Accelerating breakthroughs in the battle against the devastating neurodegenerative disease, Amyotrophic Lateral Sclerosis (ALS). ALS, colloquially known as Lou Gehrig’s disease, is a relentless condition that […]